15 Nov 2022 , 08:47 AM
Net profit of Aarey Drugs & Pharmaceuticals declined 25.35% to Rs 2.12 crore in the quarter ended September 2022 as against Rs 2.84 crore during the previous quarter ended September 2021. Sales declined 43.36% to Rs 76.26 crore in the quarter ended September 2022 as against Rs 134.65 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 76.26 | 134.65 | -43 |
| OPM % | 5.61 | 2.54 | – |
| PBDT | 2.75 | 3.62 | -24 |
| PBT | 2.33 | 3.12 | -25 |
| NP | 2.12 | 2.84 | -25 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
